Drugs / ANT-SM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01011686 | — | — | Anterogen Co., Ltd. | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ANT-SM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01011686 ↗ |
| Modality | Cell therapy | “autologous adipose-derived stem cell” NCT01011686 ↗ |